Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'L-158,809' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 35 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Baba, T; Kanda, T; Kobayashi, I
      Reduction of cardiac endothelin-1 by angiotensin II type 1 receptor antagonist in viral myocarditis of mice

      LIFE SCIENCES
    2. HONG KW; KIM CD; LEE SH; YOO SE
      THE IN-VITRO PHARMACOLOGICAL PROFILE OF KR31080, A NONPEPTIDE AT(1) RECEPTOR ANTAGONIST

      Fundamental and clinical pharmacology
    3. FULTON GJ; DAVIES MG; BARBER L; SVENDSEN E; HAGEN PO
      LOCALIZED VERSUS SYSTEMIC ANGIOTENSIN-II RECEPTOR INHIBITION OF INTIMAL HYPERPLASIA IN EXPERIMENTAL VEIN GRAFTS BY THE SPECIFIC ANGIOTENSIN-II RECEPTOR INHIBITOR L158,809

      Surgery
    4. KEATON AK; CLARK JT
      EFFECTS OF ANGIOTENSIN-II ON SEXUAL FUNCTION, BLOOD-PRESSURE, AND FLUID INTAKE ARE DIFFERENTIALLY AFFECTED BY AT-1 RECEPTOR BLOCKADE

      Physiology & behavior
    5. SHEN YT; WIEDMANN RT; GREENLAND BD; LYNCH JJ; GROSSMAN W
      COMBINED EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND ANGIOTENSIN-II RECEPTOR ANTAGONISM IN CONSCIOUS PIGS WITH CONGESTIVE-HEART-FAILURE

      Cardiovascular Research
    6. GILLIES LK; LU M; WANG H; LEE RMKW
      AT(1) RECEPTOR ANTAGONIST TREATMENT CAUSED PERSISTENT ARTERIAL FUNCTIONAL-CHANGES IN YOUNG SPONTANEOUSLY HYPERTENSIVE RATS

      Hypertension
    7. TADA H; EGASHIRA K; YAMAMOTO M; UENO H; TAKEMOTO M; SHIMOKAWA H; TAKESHITA A
      GLIBENCLAMIDE, A SPECIFIC INHIBITOR OF ATP-SENSITIVE K-II RECEPTOR ANTAGONISTS( CHANNELS, INHIBITS CORONARY VASODILATION INDUCED BY ANGIOTENSIN)

      Journal of cardiovascular pharmacology
    8. DAVIES MG; FULTON GJ; BARBER L; DALEN H; SVENDSEN E; HAGEN PO
      CHARACTERIZATION OF ANGIOTENSIN-II RECEPTOR-MEDIATED RESPONSES AND INHIBITION OF INTIMAL HYPERPLASIA IN EXPERIMENTAL VEIN GRAFTS BY THE SPECIFIC ANGIOTENSIN-II RECEPTOR INHIBITOR, L158,809

      European journal of vascular and endovascular surgery
    9. HAMILL TG; BURNS HD; DANNALS RF; MATHEWS WB; MUSACHIO JL; RAVERT HT; NAYLOR EM
      DEVELOPMENT OF [C-11] L-159,884 - A RADIOLABELED, NONPEPTIDE ANGIOTENSIN-II ANTAGONIST THAT IS USEFUL FOR ANGIOTENSIN-II, AT(1) RECEPTOR IMAGING

      Applied radiation and isotopes
    10. MOULDER JE; FISH BL; COHEN EP; BONSIB SM
      ANGIOTENSIN-II RECEPTOR ANTAGONISTS IN THE PREVENTION OF RADIATION NEPHROPATHY

      Radiation research
    11. VANKATS JP; SASSEN LMA; DANSER AHJ; POLAK MPJ; SOEI LK; DERKX FHM; SCHALEKAMP MADH; VERDOUW PD
      ASSESSMENT OF THE ROLE OF THE RENIN-ANGIOTENSIN SYSTEM IN CARDIAC CONTRACTILITY UTILIZING THE RENIN INHIBITOR REMIKIREN

      British Journal of Pharmacology
    12. GABEL RA; KIVLIGHN SD; ZINGARO GJ; SCHORN TW; SCHAFFER LW; ASHTON WT; CHANG LL; FLANAGAN K; GREENLEE WJ; SIEGL PKS
      IN-VIVO PHARMACOLOGY OF L-159,913, A NEW HIGHLY POTENT AND SELECTIVE NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST

      Clinical and experimental hypertension
    13. FITCH KJ; WALSH TF; PATCHETT AA; CHANG RSL; SIEGL PKS; FAUST KA; CHEN TB; LOTTI VJ; KIVLIGHN SD; ZINGARO GJ; GREENLEE WJ
      AT(1) SELECTIVE ANGIOTENSIN-II ANTAGONISTS WITH PHENOXYPHENYLACETIC ACID AS A BIPHENYL REPLACEMENT .1.

      Bioorganic & medicinal chemistry letters
    14. MITCHELL KD; MULLINS JJ
      ANG-II DEPENDENCE OF TUBULOGLOMERULAR FEEDBACK RESPONSIVENESS IN HYPERTENSIVE REN-2 TRANSGENIC RATS

      American journal of physiology. Renal, fluid and electrolyte physiology
    15. KIVLIGHN SD; HUCKLE WR; ZINGARO GJ; RIVERO RA; LOTTI VJ; CHANG RSL; SCHORN TW; KEVIN N; JOHNSON RG; GREENLEE WJ; SIEGL PKS
      DISCOVERY OF L-162,313 - A NONPEPTIDE THAT MIMICS THE BIOLOGICAL ACTIONS OF ANGIOTENSIN-II

      American journal of physiology. Regulatory, integrative and comparative physiology
    16. CHEN TB; BRENNER NJ; GIBSON RE; BURNS HD; CHANG RSL
      CHARACTERIZATION OF THE FINDING OF [I-125] L-735,286 - A NEW NONPEPTIDE ANGIOTENSIN-II AT(1) RECEPTOR RADIOLIGAND

      Life sciences
    17. KEISER JA; RYAN MJ; PANEK RL; HODGES JC; SIRCAR I
      PHARMACOLOGICAL CHARACTERIZATION OF CL-996, A NEW ANGIOTENSIN RECEPTOR ANTAGONIST

      The Journal of pharmacology and experimental therapeutics
    18. HILDITCH A; HUNT AAE; TRAVERS A; POLLEY J; DREW GM; MIDDLEMISS D; JUDD DB; ROSS BC; ROBERTSON MJ
      PHARMACOLOGICAL EFFECTS OF GR138950, A NOVEL ANGIOTENSIN AT(1) RECEPTOR ANTAGONIST

      The Journal of pharmacology and experimental therapeutics
    19. CHANG RSL; LOTTI VJ; CHEN TB; OMALLEY SS; BENDESKY RJ; KLING PJ; KIVLIGHN SD; SIEGL PKS; ONDEYKA D; GREENLEE WJ; MANTLO NB
      IN-VITRO PHARMACOLOGY OF AN ANGIOTENSIN AT(1) RECEPTOR ANTAGONIST WITH BALANCED AFFINITY FOR AT(2) RECEPTORS

      European journal of pharmacology
    20. KIVLIGHN SD; ZINGARO GJ; GABEL RA; BROTEN TP; CHANG RSL; ONDEYKA DL; MANTLO NB; GIBSON RE; GREENLEE WJ; SIEGL PKS
      IN-VIVO PHARMACOLOGY OF AN ANGIOTENSIN AT(1) RECEPTOR ANTAGONIST WITHBALANCED AFFINITY FOR ANGIOTENSIN AT(2) RECEPTORS

      European journal of pharmacology
    21. CHANG LL; ASHTON WT; FLANAGAN KL; RIVERO RA; CHEN TB; OMALLEY SS; ZINGARO GJ; KIVLIGHN SD; SIEGL PKS; LOTTI VJ; CHANG RSL; GREENLEE WJ
      POTENT TRIAZOLINONE-BASED ANGIOTENSIN-II RECEPTOR ANTAGONISTS WITH EQUIVALENT AFFINITY FOR BOTH THE AT(1) AND AT(2) SUBTYPES

      Bioorganic & medicinal chemistry letters
    22. GLINKA TW; DELASZLO SE; SIEGL PKS; CHANG RS; KIVLIGHN SD; SCHORN TS; FAUST KA; CHEN TB; ZINGARO GJ; LOTTI VJ; GREENLEE WJ
      DEVELOPMENT OF ANGIOTENSIN-II ANTAGONISTS WITH EQUIPOTENT AFFINITY FOR HUMAN AT(1) AND AT(2) RECEPTOR SUBTYPES

      Bioorganic & medicinal chemistry letters
    23. MANTLO NB; KIM D; ONDEYKA D; CHANG RSL; KIVLIGHN SD; SIEGL PKS; GREENLEE WJ
      IMIDAZO[4,5-B]PYRIDINE-BASED AT(1) AT(2) ANGIOTENSIN-II RECEPTOR ANTAGONISTS/

      Bioorganic & medicinal chemistry letters
    24. NAYLOR EM; CHAKRAVARTY PK; COSTELLO CA; CHANG RS; CHEN TB; FAUST KA; LOTTI VJ; KIVLIGHN SD; ZINGARO GJ; SIEGL PKS; WONG PC; CARINI DJ; WEXLER RR; PATCHETT AA; GREENLEE WJ
      POTENT IMIDAZOLE ANGIOTENSIN-II ANTAGONISTS - ACYL SULFONAMIDES AND ACYL SULFAMIDES AS TETRAZOLE REPLACEMENTS

      Bioorganic & medicinal chemistry letters
    25. CHAKRAVARTY PK; STRELITZ RA; CHEN TB; CHANG RSL; LOTTI VJ; ZINGARO GJ; SCHORN TW; KIVLIGHN SD; SIEGL PKS; PATCHETT AA; GREENLEE WJ
      QUINAZOLINONE BIPHENYL ACYLSULFONAMIDES - A POTENT NEW CLASS OF ANGIOTENSIN-II RECEPTOR ANTAGONISTS

      Bioorganic & medicinal chemistry letters
    26. CHANG LL; ASHTON WT; FLANAGAN KL; NAYLOR EM; CHAKRAVARTY PK; PATCHETT AA; GREENLEE WJ; BENDESKY RJ; CHEN TB; FAUST KA; KLING PJ; SCHAFFER LW; SCHORN TW; ZINGARO GJ; CHANG RSL; LOTTI VJ; KIVLIGHN SD; SIEGL PKS
      TRIAZOLINONES AS NONPEPTIDE ANGIOTENSIN-II ANTAGONISTS .2. DISCOVERY OF A POTENT AND ORALLY-ACTIVE TRIAZOLINONE ACYLSULFONAMIDE

      Bioorganic & medicinal chemistry letters
    27. CHANG RSL; BENDESKY RJ; CHEN TB; FAUST KA; KLING PJ; OMALLEY SA; NAYLOR EM; CHAKRAVARTY PK; PATCHETT AA; GREENLEE WJ; CLINESCHMIDT BV; LOTTI VJ
      IN-VITRO PHARMACOLOGY OF MK-996, A NEW POTENT AND SELECTIVE ANGIOTENSIN-II (AT(1)) RECEPTOR ANTAGONIST

      Drug development research
    28. CHAKRAVARTY PK; NAYLOR EM; CHEN A; CHANG RSL; CHEN TB; FAUST KA; LOTTI VJ; KIVLIGHN SD; GABLE RA; ZINGARO GJ; SCHORN TW; SCHAFFER LW; BROTEN TP; SIEGL PKS; PATCHETT AA; GREENLEE WJ
      A HIGHLY POTENT, ORALLY-ACTIVE IMIDAZO[4,5-B]PYRIDINE BIPHENYLACYLSULFONAMIDE (MK-996-L-159,282) - A NEW ANGIOTENSIN-II RECEPTOR ANTAGONIST

      Journal of medicinal chemistry
    29. ASHTON WT; CHANG LL; FLANAGAN KL; HUTCHINS SM; NAYLOR EM; CHAKRAVARTY PK; PATCHETT AA; GREENLEE WJ; CHEN TB; FAUST KA; CHANG RSL; LOTTI VJ; ZINGARO GJ; SCHORN TW; SIEGL PKS; KIVLIGHN SD
      TRIAZOLINONE BIPHENYLSULFONAMIDE DERIVATIVES AS ORALLY-ACTIVE ANGIOTENSIN-II ANTAGONISTS WITH POTENT AT(1) RECEPTOR AFFINITY AND ENHANCED AT(2) AFFINITY

      Journal of medicinal chemistry
    30. CHENG DY; DEWITT BJ; MCMAHON TJ; KADOWITZ PJ
      COMPARISON OF PRESSER RESPONSES TO ANGIOTENSIN-I, ANGIOTENSIN-II, ANDANGIOTENSIN-III IN PULMONARY VASCULAR BED OF CATS

      The American journal of physiology
    31. MANTLO NB; CHANG RSL; SIEGL PKS
      ANGIOTENSIN-II RECEPTOR ANTAGONISTS CONTAINING A PHENYLPYRIDINE ELEMENT

      Bioorganic & medicinal chemistry letters
    32. DHANOA DS; BAGLEY SW; CHANG RSL; LOTTI VJ; CHEN TB; KIVLIGHN SD; ZINGARO GJ; SIEGL PKS; PATCHETT AA; GREENLEE WJ
      NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS .1. DESIGN, SYNTHESIS,AND BIOLOGICAL-ACTIVITY OF N-SUBSTITUTED INDOLES AND DIHYDROINDOLES

      Journal of medicinal chemistry
    33. VANATTEN MK; ENSINGER CL; CHIU AT; MCCALL DE; NGUYEN TT; WEXLER RR; TIMMERMANS PBMWM
      A NOVEL SERIES OF SELECTIVE, NONPEPTIDE INHIBITORS OF ANGIOTENSIN-II BINDING TO THE AT(2) SITE

      Journal of medicinal chemistry
    34. DHANOA DS; BAGLEY SW; CHANG RSL; LOTTI VJ; CHEN TB; KIVLIGHN SD; ZINGARO GJ; SIEGL PKS; CHAKRAVARTY PK; PATCHETT AA; GREENLEE WJ
      (DIPROPYLPHENOXY)PHENYLACETIC ACIDS - A NEW-GENERATION OF NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS

      Journal of medicinal chemistry
    35. DELASZLO SE; QUAGLIATO CS; GREENLEE WJ; PATCHETT AA; CHANG RSL; LOTTI VJ; CHEN TB; SCHECK SA; FAUST KA; KIVLIGHN SS; SCHORN TS; ZINGARO GJ; SIEGL PKS
      A POTENT, ORALLY-ACTIVE, BALANCED AFFINITY ANGIOTENSIN-II AT(1) ANTAGONIST AND AT(2) BINDING INHIBITOR

      Journal of medicinal chemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/10/20 alle ore 13:31:57